Clinical trial
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety…
NCT00322595 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00322595 |
|---|---|
| Title | Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder |
| Official title | An International, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Controlled Study of the Efficacy and Safety of Sustained-Release Quetiapine Fumarate (Seroquel SR™ ) in the Treatment of Generalized Anxiety Disorder (SILVER) |
| Acronym | SILVER |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Generalized Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine fumarate, Paroxetine |
| Enrollment | 800 |
| Start date | May 1, 2006 |
| Completion | May 1, 2007 |
| First posted | May 8, 2006 |
| Last update posted | Dec 22, 2008 |
| Countries | Argentina, Bulgaria, Canada, Czechia, Denmark, Finland, France, Germany, Mexico, Norway, Romania, Slovakia and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: